Eledon Book Value Per Share from 2010 to 2024
ELDN Stock | USD 2.02 0.16 8.60% |
Book Value Per Share | First Reported 2010-12-31 | Previous Quarter 3.38837209 | Current Value 3.22 | Quarterly Volatility 797.77413758 |
Check Eledon Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eledon main balance sheet or income statement drivers, such as Depreciation And Amortization of 355.3 K, Interest Expense of 1 M or Selling General Administrative of 10.4 M, as well as many exotic indicators such as Price To Sales Ratio of 149, Dividend Yield of 9.0E-4 or PTB Ratio of 0.56. Eledon financial statements analysis is a perfect complement when working with Eledon Pharmaceuticals Valuation or Volatility modules.
Eledon | Book Value Per Share |
Latest Eledon Pharmaceuticals' Book Value Per Share Growth Pattern
Below is the plot of the Book Value Per Share of Eledon Pharmaceuticals over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Eledon Pharmaceuticals' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eledon Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
View | Last Reported 3.44 X | 10 Years Trend |
|
Book Value Per Share |
Timeline |
Eledon Book Value Per Share Regression Statistics
Arithmetic Mean | 181.81 | |
Geometric Mean | 89.36 | |
Coefficient Of Variation | 438.79 | |
Mean Deviation | 500.56 | |
Median | 11.07 | |
Standard Deviation | 797.77 | |
Sample Variance | 636,444 | |
Range | 3.2K | |
R-Value | 0.01 | |
Mean Square Error | 685,318 | |
R-Squared | 0.0001 | |
Significance | 0.97 | |
Slope | 1.96 | |
Total Sum of Squares | 8.9M |
Eledon Book Value Per Share History
Other Fundumenentals of Eledon Pharmaceuticals
Eledon Pharmaceuticals Book Value Per Share component correlations
Click cells to compare fundamentals
About Eledon Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Eledon Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Eledon Pharmaceuticals investors use historical funamental indicators, such as Eledon Pharmaceuticals's Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Eledon Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Eledon Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Eledon Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Eledon Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Eledon Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Book Value Per Share | 3.39 | 3.22 | |
Tangible Book Value Per Share | 2.07 | 1.97 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eledon Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eledon Pharmaceuticals' short interest history, or implied volatility extrapolated from Eledon Pharmaceuticals options trading.
Pair Trading with Eledon Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eledon Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Eledon Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eledon Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eledon Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eledon Pharmaceuticals to buy it.
The correlation of Eledon Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eledon Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eledon Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eledon Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Eledon Pharmaceuticals Correlation against competitors. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.Note that the Eledon Pharmaceuticals information on this page should be used as a complementary analysis to other Eledon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Eledon Stock analysis
When running Eledon Pharmaceuticals' price analysis, check to measure Eledon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eledon Pharmaceuticals is operating at the current time. Most of Eledon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eledon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eledon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eledon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Eledon Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.64) | Return On Assets (0.30) | Return On Equity (0.48) |
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.